Seagen to Present at the J.P. Morgan Healthcare Conference
Seagen announced its participation in the 39th Annual J.P. Morgan Virtual Healthcare Conference scheduled for January 11, 2021, at 2:00 p.m. ET. The presentation will be available for live webcast and replay on Seagen's website, enhancing accessibility for investors and stakeholders. As a global biotechnology company, Seagen focuses on developing transformative cancer therapies, headquartered in the Seattle area with operations across North America and Europe. For more insights and updates, visit www.seagen.com.
- None.
- None.
Seagen Inc. (Nasdaq: SGEN) today announced that management will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 2:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seagen’s website at www.seagen.com in the Investors section.
About Seagen
Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201216005222/en/
FAQ
When is Seagen presenting at the J.P. Morgan Healthcare Conference?
Where can I watch Seagen's presentation from the J.P. Morgan Conference?
What is Seagen's focus as a biotechnology company?
Is Seagen's presentation part of a larger event?